{
    "clinical_study": {
        "@rank": "80646", 
        "arm_group": [
            {
                "arm_group_label": "Reference", 
                "arm_group_type": "Placebo Comparator", 
                "description": "no added plant-based ingredients"
            }, 
            {
                "arm_group_label": "Low level plant-based ingredients", 
                "arm_group_type": "Active Comparator", 
                "description": "Low level addition of plant-based ingredients"
            }, 
            {
                "arm_group_label": "Medium level plant-based ingredients", 
                "arm_group_type": "Active Comparator", 
                "description": "Medium level addition of plant-based ingredients"
            }, 
            {
                "arm_group_label": "High level plant-based ingredients", 
                "arm_group_type": "Active Comparator", 
                "description": "High level addition of plant-based ingredients"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is designed to determine the extent to which foods containing different levels of\n      plant-based ingredients affect blood glucose responses in healthy subjects."
        }, 
        "brief_title": "Post-prandial Glucose in Healthy Subjects", 
        "condition": "Healthy Subjects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Willing to give consent to participate in the study in writing;\n\n          -  Healthy male and female subjects, between the age of \u226520 and \u226450 yrs of age at first\n             screening visit;\n\n          -  Body Mass Index (BMI) between \u226518 and \u2264 25 kg/m2;\n\n          -  Apparently healthy: no medical conditions which might affect study measurement, as\n             judged by study physician and/or measured by questionnaire, and/or assessed by\n             haematology, blood chemistry and urinalysis;\n\n          -  Willing to comply to study protocol during the study;\n\n          -  Agreeing to be informed about medically relevant personal test-results by study\n             physician;\n\n          -  Willing to refrain from drinking of alcohol on and one day before the blood\n             withdrawal;\n\n          -  Fasting blood glucose value of volunteer is \u2265 3.4 and \u2264 6.1 mmol/litre (i.e. 62-110\n             mg/dl) at screening;\n\n          -  Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for\n             females 11 to 15 gm / dL; both inclusive) as judged by the research physician.\n\n        Exclusion Criteria:\n\n          -  Being an employee of Unilever or CRO;\n\n          -  Chronic smokers, tobacco chewers and drinkers;\n\n          -  Participation in any other biomedical study 3 months before screening visit day of\n             this study and/or participating in any other biomedical study during the screening\n             period;\n\n          -  Use of medication which interferes with study measurements including vitamins,\n             tonics;\n\n          -  Reported intense exercise \u226510 h/week;\n\n          -  Reported weight loss/gain \u2265 10% of body weight in the 6 months preceding screening\n\n          -  Blood donation for 2 months prior to screening;\n\n          -  Urine analysis that showed any drug abuse;\n\n          -  Allergy to any food or cosmetics;\n\n          -  If female, not being pregnant or planning pregnancy during the study period;\n\n          -  If female, lactating or has been lactating for 6 weeks before pre-study investigation\n             and/or during the study period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955447", 
            "org_study_id": "FDS-NAA-1335"
        }, 
        "intervention": [
            {
                "arm_group_label": "Reference", 
                "description": "no added plant-based ingredients to starchy meal", 
                "intervention_name": "no added plant-based ingredients to starchy meal", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Low level plant-based ingredients", 
                "description": "Low level plant-based ingredients added to starchy meal", 
                "intervention_name": "Low level plant-based ingredients added to starchy meal", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Medium level plant-based ingredients", 
                "description": "Medium level plant-based ingredients added to starchy meal", 
                "intervention_name": "Medium level plant-based ingredients added to starchy meal", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "High level plant-based ingredients", 
                "description": "High level plant-based ingredients added to starchy meal", 
                "intervention_name": "High level plant-based ingredients added to starchy meal", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Blood glucose", 
        "lastchanged_date": "January 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ahmedabad", 
                    "country": "India"
                }, 
                "name": "Lambda Therapeutics Research Ltd (LTRL)"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Different Levels of Plant-based Ingredients on Post-prandial Glucose in Healthy Subjects", 
        "overall_official": {
            "affiliation": "Lambda Therapeutics Research Ltd (LTRL)", 
            "last_name": "Dr Ketul Modi, MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Research Ethics committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Post-prandial blood glucose area under the curve", 
            "safety_issue": "No", 
            "time_frame": "120 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955447"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Post-prandial insulin area under the curve", 
            "safety_issue": "No", 
            "time_frame": "120 minutes"
        }, 
        "source": "Unilever R&D", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Unilever R&D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}